Publication: Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia
| cris.lastimport.scopus | 2025-05-07T22:20:14Z | |
| cris.virtual.department | Pediatrics | en_US |
| cris.virtual.department | Laboratory Medicine | en_US |
| cris.virtual.department | Pediatrics-NTUH | en_US |
| cris.virtual.department | Laboratory Medicine-NTUH | en_US |
| cris.virtual.department | Pediatrics-NTUH | en_US |
| cris.virtual.department | Pediatrics | en_US |
| cris.virtual.department | Pediatrics-NTUH | en_US |
| cris.virtual.department | Pediatrics | en_US |
| cris.virtual.orcid | 0000-0002-3598-7218 | en_US |
| cris.virtual.orcid | 0000-0003-1483-0403 | en_US |
| cris.virtual.orcid | 0000-0003-4461-9967 | en_US |
| cris.virtualsource.department | f16d443d-d5c8-4c47-af3d-36a44c8450d7 | |
| cris.virtualsource.department | f16d443d-d5c8-4c47-af3d-36a44c8450d7 | |
| cris.virtualsource.department | f16d443d-d5c8-4c47-af3d-36a44c8450d7 | |
| cris.virtualsource.department | f16d443d-d5c8-4c47-af3d-36a44c8450d7 | |
| cris.virtualsource.department | 2030f71d-a1cf-4148-856e-6d9bccdc4a6e | |
| cris.virtualsource.department | 2030f71d-a1cf-4148-856e-6d9bccdc4a6e | |
| cris.virtualsource.department | 42afaab5-19fb-44b7-a50a-5d47cb55f23b | |
| cris.virtualsource.department | 42afaab5-19fb-44b7-a50a-5d47cb55f23b | |
| cris.virtualsource.orcid | f16d443d-d5c8-4c47-af3d-36a44c8450d7 | |
| cris.virtualsource.orcid | 2030f71d-a1cf-4148-856e-6d9bccdc4a6e | |
| cris.virtualsource.orcid | 42afaab5-19fb-44b7-a50a-5d47cb55f23b | |
| dc.contributor.author | Chang H.-H, MENG-YAO LU | en_US |
| dc.contributor.author | Liao Y.-M. | en_US |
| dc.contributor.author | Liao Y.-M. | en_US |
| dc.contributor.author | YUNG-LI YANG | en_US |
| dc.contributor.author | Yang Y.-L. | en_US |
| dc.contributor.author | Chiou S.-S. | en_US |
| dc.contributor.author | SHIANN-TANG JOU | en_US |
| dc.contributor.author | Lin K.-H. | en_US |
| dc.contributor.author | Chang T.-T. | en_US |
| dc.contributor.author | Chang T.-T. | en_US |
| dc.creator | Chang H.-H, Meng-Yao Lu ;Liao Y.-M. ;Lin P.-C. ;Yang Y.-L. ;Lin D.-T. ;Chiou S.-S. ;Jou S.-T. ;Lin K.-H. ;Chang T.-T. | |
| dc.date.accessioned | 2020-12-16T07:21:58Z | |
| dc.date.available | 2020-12-16T07:21:58Z | |
| dc.date.issued | 2011 | |
| dc.identifier.doi | 10.1002/pbc.22826 | |
| dc.identifier.issn | 1545-5009 | |
| dc.identifier.pmid | 21072825 | |
| dc.identifier.scopus | 2-s2.0-78651061167 | |
| dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-78651061167&doi=10.1002%2fpbc.22826&partnerID=40&md5=c22b56d3a463ade70e5e52ae70b62f00 | |
| dc.identifier.uri | https://scholars.lib.ntu.edu.tw/handle/123456789/526438 | |
| dc.relation.ispartof | Pediatric Blood and Cancer | |
| dc.relation.journalissue | 3 | |
| dc.relation.journalvolume | 56 | |
| dc.relation.pages | 420-424 | |
| dc.title | Improved efficacy and tolerability of oral deferasirox by twice-daily dosing for patients with transfusion-dependent β-thalassemia | en_US |
| dc.type | journal article | en |
| dspace.entity.type | Publication |